JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M403210200 on June 21, 2004

J. Biol. Chem., Vol. 279, Issue 35, 37153-37162, August 27, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/35/37153    most recent
M403210200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ravid, T.
Right arrow Articles by Goldkorn, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ravid, T.
Right arrow Articles by Goldkorn, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

c-Cbl-mediated Ubiquitinylation Is Required for Epidermal Growth Factor Receptor Exit from the Early Endosomes*

Tommer Ravid{ddagger}, Jill M. Heidinger{ddagger}, Peter Gee, Elaine M. Khan, and Tzipora Goldkorn§

From the Signal Transduction, Department of Internal Medicine, University of California, School of Medicine, Davis, California 95616

Epidermal growth factor receptor (EGFR) controls cell growth and has a key role in tumorigenic processes. The extent of EGFR signaling is tightly regulated by post-transcriptional modifications leading to down-regulation of the levels of the receptor. Previous studies from our laboratory demonstrated that the reactive oxidant hydrogen peroxide activates the EGFR, yet, without down-regulation of the receptor levels, which results in prolonged receptor signaling. In the present study we examined the role of the E3 ligase c-Cbl, as a possible link between oxidative stress, EGFR signaling, and tumorigenic responses. First, we ectopically expressed a mutant EGFR (Tyr-1045 -> Phe) in cells lacking endogenous receptor, to determine whether the lack of phosphorylation at this site is the cause for EGFR retention at the membrane under oxidative stress, as we have previously suggested. Our findings suggest that abrogation of tyrosine 1045 phosphorylation alone is not enough to retain the EGFR at the plasma membrane under oxidative stress. Second, through the use of the Src inhibitor PP1, our findings establish EGFR movement out of the early endosomes as the exact location where c-Cbl-mediated ubiquitinylation is essential for EGFR trafficking. Finally, our studies substantiate the findings that c-Cbl-mediated ubiquitinylation is needed for degradation, but not for internalization of the EGFR in both transfection-dependent Chinese hamster ovary cells and transfection-independent A549 lung epithelial cells. These findings only begin to explain the features seen under oxidative stress, but they yield a greater understanding of the role of c-Cbl in EGFR trafficking.


Received for publication, March 23, 2004 , and in revised form, June 7, 2004.

* This work was supported by National Institutes of Health Grants HL66189 and HL71871 (to T. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Both authors contributed equally to this work.

§ To whom correspondence should be addressed: Dept. of Signal Transduction, School of Medicine, TB 149, Davis Campus, University of California, Davis, CA 95616. Tel.: 530-752-2988; Fax: 530-752-2949; E-mail: ttgoldkorn{at}ucdavis.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
K. Umebayashi, H. Stenmark, and T. Yoshimori
Ubc4/5 and c-Cbl Continue to Ubiquitinate EGF Receptor after Internalization to Facilitate Polyubiquitination and Degradation
Mol. Biol. Cell, August 1, 2008; 19(8): 3454 - 3462.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Pennock and Z. Wang
A Tale of Two Cbls: Interplay of c-Cbl and Cbl-b in Epidermal Growth Factor Receptor Downregulation
Mol. Cell. Biol., May 1, 2008; 28(9): 3020 - 3037.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. M. Khan, R. Lanir, A. R. Danielson, and T. Goldkorn
Epidermal growth factor receptor exposed to cigarette smoke is aberrantly activated and undergoes perinuclear trafficking
FASEB J, March 1, 2008; 22(3): 910 - 917.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Su, C. Kong, and P. D. Stahl
GAPex-5 Mediates Ubiquitination, Trafficking, and Degradation of Epidermal Growth Factor Receptor
J. Biol. Chem., July 20, 2007; 282(29): 21278 - 21284.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. V. Grandal, R. Zandi, M. W. Pedersen, B. M. Willumsen, B. van Deurs, and H. S. Poulsen
EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes
Carcinogenesis, July 1, 2007; 28(7): 1408 - 1417.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
L. Bonaccorsi, D. Nosi, M. Muratori, L. Formigli, G. Forti, and E. Baldi
Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines
J. Mol. Endocrinol., January 1, 2007; 38(1): 51 - 66.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Lennartsson, P. Wardega, U. Engstrom, U. Hellman, and C.-H. Heldin
Alix Facilitates the Interaction between c-Cbl and Platelet-derived Growth Factor beta-Receptor and Thereby Modulates Receptor Down-regulation
J. Biol. Chem., December 22, 2006; 281(51): 39152 - 39158.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. D. Carey, A. J. Garton, M. S. Romero, J. Kahler, S. Thomson, S. Ross, F. Park, J. D. Haley, N. Gibson, and M. X. Sliwkowski
Kinetic Analysis of Epidermal Growth Factor Receptor Somatic Mutant Proteins Shows Increased Sensitivity to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Erlotinib
Cancer Res., August 15, 2006; 66(16): 8163 - 8171.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Khan, J. M. Heidinger, M. Levy, M. P. Lisanti, T. Ravid, and T. Goldkorn
Epidermal Growth Factor Receptor Exposed to Oxidative Stress Undergoes Src- and Caveolin-1-dependent Perinuclear Trafficking
J. Biol. Chem., May 19, 2006; 281(20): 14486 - 14493.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.